Outlook Therapeutics shareholders approve increase in authorized common shares to 600 million

Outlook Therapeutics, Inc.

Outlook Therapeutics, Inc.

OTLK

0.00
  • Outlook Therapeutics shareholders met July 16, 2026, backing a charter amendment to raise authorized common shares to 600 million from 260 million.
  • The authorized-share increase was executed the same day through a filed certificate of amendment, effective July 16, 2026.
  • Shareholders also cleared potential share issuance tied to April 2026 private placement warrants and placement agent warrants covering up to 18,387,097 shares.
  • A separate authorization passed for potential share issuance from amended, previously issued warrants covering up to 2,142,854 shares.
  • Shareholders also approved a reverse stock split range of 1-for-10 to 1-for-50, with the final ratio left to the board.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outlook Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-084242), on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.